Update on fosfomycin-modified genes in Enterobacteriaceae
The long-used antibiotic fosfomycin has recently been re-evaluated as a potential regimen for treating extended-spectrum β-lactamases (ESBLs) and carbapenem-resistant Enterobacteriaceae (CRE). Fosfomycin is known for its robust bactericidal effect against ESBL-producing Enterobacteriaceae and CRE. H...
Main Authors: | Tsung-Ying Yang, Po-Liang Lu, Sung-Pin Tseng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-02-01
|
Series: | Journal of Microbiology, Immunology and Infection |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1684118217302578 |
Similar Items
-
Identification of Fosfomycin Heteroresistance Among Multidrug-Resistant Enterobacteriaceae Urinary Isolates
by: Mallika Sengupta, et al.
Published: (2020-06-01) -
Fosfomycin, a therapeutic option for infections produced by multiple drug-resistant Enterobacteriaceae
by: Fatemeh Yeganeh Sefidan, et al.
Published: (2016-07-01) -
The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan
by: Sung-Pin Tseng, et al.
Published: (2017-10-01) -
Some Enterobacteriaceae Species Isolated from Urine Cultures and Their Susceptibilities to Fosfomycin and Other Antibiotics
by: Nadire Seval GÜNDEM, et al.
Published: (2013-03-01) -
In vitro fosfomycin study on concordance of susceptibility testing methods against ESBL and carbapenem-resistant Enterobacteriaceae
by: Ausilia Aprile, et al.
Published: (2020-12-01)